ESC 365 - Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction

Back

HFA Premium Access

Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction - A nationwide cohort study

Session: Rapid Fire 4 - Therapy and management

Topic: Chronic pulmonary hypertension

Speaker: Doctor O. Vedin (Uppsala, SE)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Ola Vedin

Uppsala University Hospital, Uppsala (Sweden)

0 follower

13 more presentations in this session

Physical activity measured with implanted devices predicts heart failure outcomes

Speaker: Professor C. Linde (Stockholm, SE)

Age and effect of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure.

Speaker: Mrs M. Elming (Copenhagen, DK)

Use of mineralocorticoid receptor antagonists in a real-world population with heart failure and reduced ejection fraction: an analysis of 24,529 patients from the swedish heart failure registry

Speaker: Doctor G. Savarese (Stockholm, SE)

Oral anticoagulant use in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,719 patients from the swedish heart failure registry

Speaker: Doctor G. Savarese (Stockholm, SE)

SGLT2 inhibition differentially reduces extracellular fluid volume relative to blood volume: a hypothesis for heart failure protection

Speaker: Assistant Professor M. Hallow (Athens, GA, US)

Access the full session

Rapid Fire 4 - Therapy and management

Speakers: Doctor O. Vedin, Professor C. Linde, Mrs M. Elming, Doctor G. Savarese, Doctor G. Savarese...

Access

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources